Ponatinib Hydrochloride 10 mg, 15 mg, 30 mg, 45 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg, 15 mg, 30 mg, 45 mg
Reference Brands: Iclusig (USA)
Category: Oncology Cancer Care
Ponatinib is a third-generation tyrosine kinase inhibitor that targets BCR‑ABL, including the T315I mutation, which is resistant to earlier TKIs. It is used primarily to treat chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia
Ponatinib Hydrochloride — third party manufacturing & bulk supply
Ponatinib Hydrochloride 10 mg, 15 mg, 30 mg, 45 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ponatinib Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ponatinib Hydrochloride →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ponatinib Hydrochloride is used for the treatment of certain types of blood cancers, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), particularly in patients resistant to other therapies.
It is made from ponatinib hydrochloride, a tyrosine kinase inhibitor synthesized to block the activity of the BCR-ABL protein that drives cancer cell growth.
The commonly known trade name is Iclusig.
Iclusig is marketed by Takeda Pharmaceuticals.
The generic name is ponatinib hydrochloride.
The well-known brand name is Iclusig.
Ponatinib Hydrochloride is manufactured in countries including India, the USA, and select EU regions by branded and generic pharmaceutical manufacturers.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
